PHILADELPHIA – More lawsuits are alleging that Johnson & Johnson’s diabetes medication, Invokana, gave them an increased risk of suffering amputations – and that the company failed to warn them of that same risk.
PHILADELPHIA – A trio of new lawsuits joins others recently filed taking aim at Johnson & Johnson’s Invokana medication for Type 2 diabetes, claiming the company failed to warn its users that the medicine put them at increased risk for amputations they suffered as a result of taking the drug.
All it takes is one maturing into a headline-grabbing, multimillion-dollar verdict to spawn thousands more like it.
Lawsuit: Hershey forced out older white employees for young minority hires
By signing up you agree to receive email newsletters or alerts from Pennsylvania Record. You can unsubscribe at any time.
Alerts Sign-up
Alerts Sign-up
